A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.

CONCLUSION: Both, 80 and 120 mg doses of Sii Onco BCG are effective and safe for prophylaxis and management of NMIBC. PMID: 32037199 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32037199?dopt=Abstract

Source: Urologic Oncology - February 5, 2020 Category: Urology & Nephrology Authors: Sood R, Sharma H, Sharma B, Parekh S, Pujari P, Shewale S Tags: Urol Oncol Source Type: research